数字乳腺断层合成在可触及乳腺异常评估中的诊断准确性。
理由与目的:数字乳腺断层合成(DBT)在评估可触及异常中的作用尚未得到评估,其与二维乳腺X线摄影相比的准确性尚不清楚。本研究的目的是评估可触及部位联合二维乳腺X线摄影、DBT和超声(US)的应用。材料与方法:两名乳腺影像医师对因可触及主诉而进行的联合二维乳腺X线摄影和DBT检查的连续病例进行盲法审阅。…
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The role of digital breast tomosynthesis (DBT) in evaluating palpable abnormalities has not been evaluated and its accuracy compared to 2D mammography is unknown. The purpose of this study was to evaluate combined 2D mammography, DBT, and ultrasound (US) at palpable sites.
MATERIALS AND METHODS: Two breast imagers reviewed blinded consecutive cases with combined 2D mammograms and DBT examinations performed for palpable complaints. By consensus, 2D and DBT findings were recorded and compared to US. Patient characteristics, demographics, subsequent workup, and outcome were recorded.
RESULTS: A total of 229 sites in 188 patients were included, with 50 biopsies performed identifying 18 cancers. All 18 cancers were identified on 2D and US, whereas 17 cancers were identified on DBT. Cancer detection sensitivities for 2D, DBT, and US were 100.0%, 94.4%, and 100.0%. The negative predictive value, when combined with US, was 100% for both. The sensitivity and the specificity for both benign and malignant findings with 2D and DBT were 70.5% versus 75.4% (P = 0.07) and 95.3% versus 99.1% (P = 0.125). Palpable findings not identified by 2D and DBT were smaller than those identified (11.5 ± 8.3 mm vs 23.9 ± 12.8 mm, P < 0.001). Patients with dense breasts were more likely to have mammographically occult findings than patients with nondense breasts (27.4% vs 8.3%).
CONCLUSIONS: DBT did not improve cancer detection over 2D or US. Both mammographic modalities failed to identify sonographically confirmed findings primarily in dense breasts. The diagnostic use of DBT at palpable sites provided limited benefit over combined 2D and US. When utilizing DBT, US should be performed to adequately characterize palpable sites.
引用
- Hawley JR, Kang-Chapman JK, Bonnet SE, et al. Diagnostic Accuracy of Digital Breast Tomosynthesis in the Evaluation of Palpable Breast Abnormalities. Acad Radiol. 2017. PMID: 29174225. doi:10.1016/j.acra.2017.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。